Q3 2025 Hinge Health Inc Earnings Call Transcript

Nov 4, 2025 / 09:30 PM GMT

Release Date Price: $53.44 (+6.16%)

Transcript 10-Q8-K

Key Points

Positve

Hinge Health Inc (HNGE) reported a 53% year-over-year revenue growth, reaching $154 million for Q3 2025.
The company achieved a gross margin of 83%, up from 79% in the previous year, showcasing improved operational efficiency.
Hinge Health Inc (HNGE) generated $81 million in free cash flow this quarter, highlighting strong cash generation capabilities.
The company has successfully integrated AI into its operations, increasing code output by 120% and improving developer experience scores by 32%.
Hinge Health Inc (HNGE) expanded its client base by 25% year-over-year, ending Q3 with 2,560 contracted clients.

Negative

Despite strong performance, the company anticipates a seasonal slowdown in Q4 compared to Q3, which is typical except for the anomaly in 2024.
There is concern about the potential impact of a prolonged federal government shutdown on health benefits and operations.
The company faces challenges in scaling its Hinge Select provider network, which requires building a two-sided marketplace.
Hinge Health Inc (HNGE) is investing heavily in R&D and new product development, which could impact short-term profitability.
The transition to a new engagement-based pricing model may pose risks to billing and collections processes.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HNGE.N - Hinge Health Inc
Q3 2025 Hinge Health Inc Earnings Call
Nov 04, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for joining us and welcome to the Hinge Health Third quarter 2025 earnings call. After today's prepared remarks, we will host a question-and-answer session. If you would like to ask a question, please raise your hand. If you have dialed in to today's call, please press 9 to raise your hand and 6 to unmute. I will now hand the conference over to Bianca Buck, head of investor relations. Bianca, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon and welcome to Hinge Health's 3rd quarter 2025 earnings call. I'm Bianca Buck, head of

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.